(Q51891134)

17 April 2018

title

Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. (English)

1 reference

17 April 2018

0 references

Cornelia Tolg

1

1 reference

17 April 2018

Nesrin Sabha

2

1 reference

17 April 2018

Rene Cortese

3

1 reference

17 April 2018

Trupti Panchal

4

1 reference

17 April 2018

Alya Ahsan

5

1 reference

17 April 2018

Ashraf Soliman

6

1 reference

17 April 2018

Karen J Aitken

7

1 reference

17 April 2018

Arturas Petronis

8

1 reference

17 April 2018

Darius J Bägli

9

1 reference

17 April 2018

publication date

17 January 2011

1 reference

17 April 2018

published in

Laboratory Investigation

1 reference

17 April 2018

volume

91

1 reference

17 April 2018

issue

6

1 reference

17 April 2018

page(s)

825-836

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.197

exact match

0 references

cites work

Urologic diseases in America Project: analytical methods and principal findings.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Urinary tract infections and reduced risk of bladder cancer in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Diagnosis and treatment of uncomplicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Type 1 pilus-mediated bacterial invasion of bladder epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Current concepts of molecular defence mechanisms operative during urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Innate and adaptive immune responses in the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Pathogenesis of urinary tract infections with normal female anatomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Urinary tract diseases revealed after DTP vaccination in infants and young children: cytokine irregularities and down-regulation of cytochrome P-450 enzymes induced by the vaccine may uncover latent diseases in genetically predisposed subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

A toll-like receptor that prevents infection by uropathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

DNA methylation as a marker for the past and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Demonstration and characterization of mutations induced by Helicobacter pylori organisms in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Viral oncoproteins target the DNA methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Mismatch repair in correction of replication errors and processing of DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Epigenetic silencing of the MGMT gene in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Detection of intracellular bacterial communities in human urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

DNA methylation based biomarkers in non-invasive cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Circulating nucleic acids as a potential source for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Utility of DNA methylation markers for diagnosing cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

DNA methylation and cancer diagnosis: new methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

FimH can directly activate human and murine natural killer cells via TLR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Genetic risk for recurrent urinary tract infections in humans: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

The probiotic approach: an alternative treatment option in urology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

Heat Shock Protein 72 (HSPA1B) Gene Polymorphism and Toll-Like Receptor (TLR) 4 Mutation Are Associated with Increased Risk of Urinary Tract Infection in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

The burden of urologic diseases in America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

7 January 2021

Urinary tract infection and risk of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

7 January 2021

Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

7 January 2021

Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

7 January 2021

Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

7 January 2021

DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

7 January 2021

Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.197

7 January 2021

10.1038/LABINVEST.2010.197

Identifiers

DOI

1 reference

17 April 2018

Dimensions Publication ID

1034546261

0 references

Fatcat ID

release_jdbtceblufaybo2orhvn5avw7a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jdbtceblufaybo2orhvn5avw7a

24 November 2022

mapped directly with Wikidata item

PubMed ID

21242958

1 reference

17 April 2018